The department of Nuclear Medicine was started in the year 1988 with two planar gamma cameras, a Headtome; a dedicated SPECT system for the head and a dual photon x-ray bone densitometer. It was the only Nuclear Medicine department in this region at that time and offered diagnostic as well as therapeutic services to people of the U.P and neighbouring states. The department performs over ten thousand diagnostic and therapeutic procedures per year using various radioisotopes at a reasonable cost.
Ever since the department has kept pace with developments in this field and continued to progress and moved on to incorporate newer technology of SPECT-CT and acquired three such systems. After adding PET-CT imaging for general oncology and neuro-endocrine tumours, the department is counted among the leading centres of the country which offer such advanced imaging services for patients. The establishment of the Cyclotron facility enhances the number of patients diagnosed as well as new radio-labelled tracers such as 11C-Methionine, 11C-Choline, 13N-NH3, 18F-FES, Ga-68 such as 68Ga-PSMA617, 68Ga-PSMA11, 68Ga-DOTANOC, 68Ga-FAPI04 based peptides were introduced to diagnose various diseases. With the production of Cu-64 radio-isotope, we stand first in the country and also very few centres around the globe having such a facility. The produced Cu-64 was used for diagnostic and its therapeutic potential to be explored soon due to the capability of this isotope to be used as a therapeutic radioisotope.
Area of Interest:
Exploration of Solid Target Material and production of different radioisotopes such as Ga-68, Ti-45, and Zr-89.
Development of Glu-Ureido-based scaffolds for prostate cancer imaging and therapy.
- Development of PET-based radiotracer for brain imaging.
- Development of beta-amyloid tau-based scaffolds.
- Development of radiolabelled nanoparticles.
Gallery
35th Foundation Day 2024
